Research Topics
| Sara A CoryaSummaryAffiliation: Eli Lilly and Company Country: USA Publications
|
Detail Information
Publications
Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label studySara A Corya
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
J Clin Psychiatry 64:1349-56. 2003..Long-term efficacy and safety were therefore investigated in a group of patients with major depressive disorder (MDD) with and without TRD...- A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depressionSara A Corya
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
Depress Anxiety 23:364-72. 2006..e., olanzapine and fluoxetine), showed a rapid onset of antidepressant effect, and was effective in this TRD sample. At the study end point, OFC, fluoxetine, venlafaxine, and low-dose OFC all appeared to be similarly effective... - A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depressionSara A Corya
Lilly Research Laboratories, Indianapolis, Ind, USA
J Clin Psychiatry 67:798-806. 2006..The present analyses examined the efficacy and safety of longer term treatment with olanzapine-fluoxetine combination or olanzapine monotherapy in a 6-month open-label extension study... 
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of casesHolland C Detke
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
BMC Psychiatry 10:43. 2010..During clinical trials, a post-injection syndrome characterized by signs of delirium and/or excessive sedation was identified in a small percentage of patients following injection with olanzapine LAI...- Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorderScott W Andersen
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
J Clin Psychiatry 66:1468-76. 2005..It is important that prescribers balance the risk of weight gain with the benefit of treatment for individual patients with depression... 
Metabolic parameters in patients treated with olanzapine or other atypical antipsychoticsOlawale Osuntokun
Eli Lilly and Company, Indianapolis, IN 46285 6156, USA
J Psychopharmacol 25:630-8. 2011..04 mmol/L [N = 220; ME = 194], p = 0.048). The study concluded that there are changes with varying frequencies and magnitude in some metabolic parameters in patients treated with olanzapine compared with other atypical antipsychotics...- Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depressionPaul E Keck
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
J Clin Psychiatry 66:611-6. 2005..These subanalyses compare treatment-emergent mania rates in bipolar I depressed patients treated with olanzapine, placebo, or olanzapine/fluoxetine combination... - Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistanceRichard C Shelton
Department of Psychiatry, Vanderbilt University, Nashville, TN 37212, USA
J Clin Psychiatry 66:1289-97. 2005.... - A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorderMichael E Thase
Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
J Clin Psychiatry 68:224-36. 2007..Two parallel, 8-week double-blind studies compared olanzapine/fluoxetine combination, olanzapine, and fluoxetine in outpatients with treatment-resistant depression (TRD)...